MYC and metabolic dysfunction-associated steatotic liver disease: Furthermore, DEG data also indicated that MYC, which is highly expressed in chronic liver diseases like MASLD and hepatocellular carcinoma (HCC) 32-34, was significantly increased in mouse liver tissue obtained from HFD+PS-NPs group (Fig. S2 and 4D).